The Foreign Minister of Russia, Sergey Lavrov has disclosed that Russia plans to supply Pakistan with 150,000 doses of the Sputnik V COVID-19 vaccine developed in Russia, news company CNN reported on Wednesday.
The private sector in Pakistan has already reportedly purchased 50,000 doses of the Sputnik V vaccine and these are currently being sold commercially.
According to the latest tally from Johns Hopkins University, since the start of the pandemic Pakistan has recorded over 700,000 cases of COVID-19 and more than 15,000 deaths related to the disease.
CNN also reported that Russia has recently announced agreements with 20 manufacturers in 10 different countries to produce its Sputnik V vaccine.
Circio unveils circVec proof-of-concept
GSK releases decade-long data on Shingrix efficacy
BiVictriX receives FDA Orphan Drug Designation for AML treatment candidate
GSK announces positive EAGLE-1 results for gepotidacin in gonorrhoea treatment
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Amneal announces launch of PEMRYDI RTU, a ready-to-use oncology injectable
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
GSK's meningitis vaccine candidate accepted for FDA review
Medivir and Vetbiolix report positive results from VBX-1000 Proof-of-Concept clinical study
Norgine submits first marketing authorisation application submissions for approval of eflornithine
Innovent Biologics names new Oncology CMO
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
ProAxsis secures GBP1.8m investment
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients